BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37558648)

  • 21. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR; Thapaliya S; Tkach JA; Trout AT
    AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic Extracellular Volume Fraction Derived Using Virtual Unenhanced Attenuation of Blood on Contrast-Enhanced Cardiac Dual-Energy CT in Nonischemic Cardiomyopathy.
    Kim NY; Im DJ; Youn JC; Hong YJ; Choi BW; Kang SM; Lee HJ
    AJR Am J Roentgenol; 2022 Mar; 218(3):454-461. PubMed ID: 34643105
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis.
    Kukuk GM; Hittatiya K; Sprinkart AM; Eggers H; Gieseke J; Block W; Moeller P; Willinek WA; Spengler U; Trebicka J; Fischer HP; Schild HH; Träber F
    Eur Radiol; 2015 Oct; 25(10):2869-79. PubMed ID: 25903702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automated hepatic steatosis assessment on dual-energy CT-derived virtual non-contrast images through fully-automated 3D organ segmentation.
    Jeon SK; Joo I; Park J; Yoo J
    Radiol Med; 2024 Jun; ():. PubMed ID: 38869829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimaterial decomposition algorithm for quantification of fat in hepatocellular carcinoma using rapid kilovoltage-switching dual-energy CT: A comparison with chemical-shift MR imaging.
    Ota T; Hori M; Sasaki K; Onishi H; Nakamoto A; Tatsumi M; Fukui H; Ogawa K; Tomiyama N
    Medicine (Baltimore); 2021 May; 100(20):e26109. PubMed ID: 34011134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
    Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of Dual-Energy Computed Tomography Techniques for Fat Quantification in Comparison With Magnetic Resonance Proton Density Fat Fraction and Single-Energy Computed Tomography in an Anthropomorphic Phantom Environment.
    Wu ZJ; Hippe DS; Zamora DA; Briller N; Amin KA; Kolokythas O; Mileto A
    J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):877-887. PubMed ID: 34469903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
    Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
    Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of hepatic steatosis using dual-energy CT with MR comparison.
    Sun T; Lin X; Chen K
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1377-85. PubMed ID: 24896357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
    Pickhardt PJ; Graffy PM; Reeder SB; Hernando D; Li K
    AJR Am J Roentgenol; 2018 Sep; 211(3):W151-W157. PubMed ID: 30016142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques.
    Wu CH; Ho MC; Jeng YM; Hsu CY; Liang PC; Hu RH; Lai HS; Shih TT
    J Gastroenterol Hepatol; 2014 Apr; 29(4):807-13. PubMed ID: 24224538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy.
    Bashir MR; Zhong X; Nickel MD; Fananapazir G; Kannengiesser SA; Kiefer B; Dale BM
    AJR Am J Roentgenol; 2015 Feb; 204(2):297-306. PubMed ID: 25615751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
    Kaltenbach B; Wichmann JL; Pfeifer S; Albrecht MH; Booz C; Lenga L; Hammerstingl R; D'Angelo T; Vogl TJ; Martin SS
    Eur J Radiol; 2018 Aug; 105():20-24. PubMed ID: 30017280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index.
    Lee SW; Park SH; Kim KW; Choi EK; Shin YM; Kim PN; Lee KH; Yu ES; Hwang S; Lee SG
    Radiology; 2007 Aug; 244(2):479-85. PubMed ID: 17641368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-individual Comparisons of the Ultrasound-Guided Attenuation Parameter and the Magnetic Resonance Imaging-Based Proton Density Fat Fraction Using Bias and Precision Statistics.
    Kumada T; Ogawa S; Goto T; Toyoda H; Yasuda S; Ito T; Yasuda E; Akita T; Tanaka J
    Ultrasound Med Biol; 2022 Aug; 48(8):1537-1546. PubMed ID: 35613974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound attenuation imaging: a reproducible alternative for the noninvasive quantitative assessment of hepatic steatosis in children.
    Dardanelli EP; Orozco ME; Oliva V; Lutereau JF; Ferrari FA; Bravo MG; Ruvinsky S; Roel M; Barvosa PC; Armeno M; Kaplan JS
    Pediatr Radiol; 2023 Jul; 53(8):1618-1628. PubMed ID: 36869263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of US attenuation imaging for the detection and severity grading of hepatic steatosis in routine abdominal ultrasonography.
    Kwon EY; Kim YR; Kang DM; Yoon KH; Lee YH
    Clin Imaging; 2021 Aug; 76():53-59. PubMed ID: 33549920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters.
    Yoo J; Joo I; Jeon SK; Park J; Yoon SH
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38393403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.